Clinica Chimica Acta:原发性开角型青光眼患者的眼泪中可以得到什么信息?

2019-10-17 gladiator MedSci原创

眼泪是对眼科疾病有潜在的诊断价值一种生物液体。

眼泪是对眼科疾病有潜在的诊断价值一种生物液体。本研究的目的是利用透射电镜(TEM)和分子生物学方法,比较原发性开角型青光眼(POAG)患者和健康人(HPs)的泪液上清液和微滴。

采用超滤法和超离心法制备泪液上清和微滴,采用阴性染色法和免疫金标记TEM法进行检测。 使用MiSeqIllumina,美国)基因组测序仪和Reagent Kit v3600cyclesIllumina,美国)对沉淀的DNA进行分离,定量和测序。 从沉淀中分离和定量MicroRNA;使用TaqMan MicroRNA检测miR-146bmiR-16miR-126(应用生物系统,美国)

POAG患者和HPs患者的泪液上清液进行透射电镜观察发现了相同的成分:包括球形或杯状囊泡、“非囊泡”、细胞碎片和高分子聚集物。POAG患者和HPs患者含有小的细胞外囊泡(sEVs),无标记囊泡和“无囊泡”;来自病人的微粒中含有带有“胶囊”的sEVsPOAG患者泪液微粒与HPs泪液微粒相比,基因组ds-DNASINE-repeats浓度升高,miR-146bmiR-16miR-126表达不同,细菌DNA组不同。

所获得的数据表明,HPsPOAG患者的眼泪可作为TEM研究的对象,并可作为含sEV制剂(小丸)的来源,进而可用于分离和研究基因组ds- DNARNA 我们的数据为将眼泪用于诊断应用提供了基础。

原始出处:

Svetlana TamkovichAlina Grigor'evaWhat information can be obtained from the tears of a patient with primary open angle glaucoma?

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]
    2021-06-17 147d8889m87暂无昵称

    好文章,具有启发意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]
    2020-05-25 windight
  6. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]
    2019-10-19 xiay994457
  7. [GetPortalCommentsPageByObjectIdResponse(id=974276, encodeId=ce109e427610, content=好文章,具有启发意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/576833203e2d424c95ef27ec0d7733f1/ebf44b031a5945aba799dafaa1b4bf02.jpg, createdBy=85bd5248888, createdName=147d8889m87暂无昵称, createdTime=Thu Jun 17 07:59:33 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046552, encodeId=3d622046552ec, content=<a href='/topic/show?id=4c924968e24' target=_blank style='color:#2F92EE;'>#开角型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49687, encryptionId=4c924968e24, topicName=开角型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sun Aug 30 15:59:00 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846824, encodeId=77d31846824b2, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Fri Sep 11 21:59:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687930, encodeId=b5c1168e9309b, content=<a href='/topic/show?id=b2653e05827' target=_blank style='color:#2F92EE;'>#原发性开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37058, encryptionId=b2653e05827, topicName=原发性开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1c428418693, createdName=ms3323097325231039, createdTime=Tue Jun 09 11:59:00 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849759, encodeId=efcc1849e59fd, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Mon May 25 08:59:00 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540476, encodeId=d98e15404e6c8, content=<a href='/topic/show?id=1ee5e2768ec' target=_blank style='color:#2F92EE;'>#眼泪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72768, encryptionId=1ee5e2768ec, topicName=眼泪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f93b13252554, createdName=xiay994457, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630789, encodeId=092b1630e8947, content=<a href='/topic/show?id=b42049688fb' target=_blank style='color:#2F92EE;'>#开角型青光眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49688, encryptionId=b42049688fb, topicName=开角型青光眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e50021580175, createdName=surilei, createdTime=Sat Oct 19 12:59:00 CST 2019, time=2019-10-19, status=1, ipAttribution=)]